U.S – Sterilex LLC, at the forefront of developing innovative food safety antimicrobial products, is undergoing a strategic leadership transition.
CEO Alex Josowitz, credited with steering Sterilex through record growth and market expansion, is transitioning to a strategic advisory role. Colleen Akehurst, a seasoned executive with a track record in overseeing CEO transitions, steps in as interim CEO.
The move positions Sterilex for continued success and innovation in addressing the food industry’s microbial challenges.
Sterilex is a leading developer of innovative solutions that improve food safety and enhance public health.
It addresses sanitation and microbial challenges through its line of proprietary, award-winning biofilm-control biocides, broad-spectrum disinfectants and rapid biofilm diagnostic tools in the food processing, animal health and water treatment industries
Under Josowitz’s stewardship, Sterilex achieved remarkable year-over-year growth, marked by market expansion and the successful launch of new products designed to address critical microbial challenges in the industry.
Josowitz’s innovative leadership, according to the company, propelled Sterilex into a market leader, making substantial contributions to the food safety landscape. His legacy includes a strategic vision that drove sustained growth.
While transitioning from the CEO position, Josowitz assumes a strategic advisory role and remains an integral part of the company by serving on the Board of Directors. His ongoing involvement signifies a commitment to Sterilex’s continued success.
Akehurst, a Managing Director at Paine Schwartz Partners, brings a wealth of experience to her role as interim CEO.
With a background in overseeing CEO transitions, particularly in family-owned businesses, Akehurst is poised to guide Sterilex through this transformative phase.
Akehurst’s career spans CEO roles in start-ups and family-owned consumer product companies. She has also held key leadership positions in marketing and global strategy at industry giants such as Heinz and Mondelez.
Akehurst’s success in CEO transitions, coupled with her experience in diverse leadership roles, positions her as a valuable asset to Sterilex during this transition period, says the company.
Akehurst, working closely with the Sterilex team, aims to seamlessly bridge the organization from Josowitz’s leadership to the next CEO. Her strategic insights and industry acumen will play a pivotal role in steering Sterilex into its next phase of growth.
“I look forward to working with the Sterilex leadership team and Alex in his continuing board role to continue growing this incredible business and its portfolio of innovative products,” Akehurst said.
Rick Greubel, Chairman of the Sterilex Board, expressed gratitude to Josowitz for his visionary leadership and building an innovative food safety antimicrobial business. The Board anticipates continued collaboration with Josowitz in his new role on the Board.